Published in Pharmacoeconomics on January 01, 1992
Ethics and evidence based medicine. BMJ (1998) 1.74
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. Value Health (2012) 1.16
Drug policy down under: Australia's pharmaceutical benefits scheme. Health Care Financ Rev (2004) 1.15
The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines. Aust New Zealand Health Policy (2007) 0.99
Recent developments in targeting access to high cost medicines in Australia. Aust New Zealand Health Policy (2005) 0.84
Are quality of life, patient preferences, and costs realistic outcomes for clinical trials? Support Care Cancer (1997) 0.77
Economics and the fundamental principles of the NHS. BMJ (1992) 0.75
Health state descriptions to elicit stroke values: do they reflect patient experience of stroke? BMC Health Serv Res (2014) 0.75
Costs, innovation and efficiency in anti-infective therapy. Pharmacoeconomics (1996) 0.75